肝动脉栓塞微球是用于治疗中晚期肝癌的新剂型。
The microsphere for hepatic arterial embolization is a newdosage form for treatment of non-resectable liver cancer.
肝动脉栓塞微球是用于治疗中晚期肝癌的新剂型。
The microsphere for hepatic arterial embolization is a new dosage form in the treatment of non-resectable liver cancer.
目的探讨门静脉栓塞的安全范围及白芨微球作为门静脉栓塞剂的可行性与有效性。
Objective To discuss the safety limit of portal vein embolization, to evaluate the feasibility and efficacy of Bletilla microsphere used as an embolic agent for portal vein.
目的研究采用微球联合碘油作为栓塞剂治疗肝癌的安全性及疗效。
Objective to study the safety and efficacy of transhepatic arterial infusion embolization using microspheres combined with lipiodol for treatment of hepatocellular carcinoma (HCC).
结果门脉造影显示葡聚糖微球栓塞门静脉末梢分支。
Results Transhepatic portal venography performed after each embolization revealed diffuse PV branch occlusion in all cases.
探索茶多酚磁性白蛋白微球的制备工艺，用作治疗肿瘤的新型动脉栓塞制剂。
To explore the method of preparing tea polyphenols magnetic albumin microspheres, which are used to a new arterial embolization formulation.
结论经肝动脉超选择性灌注32 P玻璃微球内照射化疗栓塞治疗肝癌是一种安全有效的方法。
Conclusions Super selective intra-arterial radioembolization with 32 P-glass microspheres is an effective and safe method in treatment of liver cancer.
方法应用海藻酸钠微球(KMG)和微导管系统对常规导管不能超选择的18例脾功能亢进患者行部分性脾栓塞术。
Methods PSE by using KMG particles and by using microcatheter in 18 patients with hypersplenism, who were unable to adopt the conventional catheter.
用乳化化学交联法制备出适合于颌面部鳞癌殒外动脉栓塞用顺铂白蛋白微球；
In this paper the technique of emulsion chemical-crosslinking was used to prepare cisplatin albumin microsphere for jaw squamous cancer by neck external artery embolization.
目的：探讨3 2磷玻璃微球内放射栓塞治疗中晚期肝癌的效果。
Objective:To determine the therapeutic effects of hepatic radioembolization with phosphorus 32 glass microsphere( 32 P GMS) in the treatment of hepatocellular carcinoma(HCC).
平均生存期A组10.6月、B组7.6月。 顺铂微球加碘化油栓塞的效果明显高于化疗药物碘化油栓塞的效果。
The mean survival time was 10.6 months and 7.6 months in group A and group B respectively.
平均生存期A组10.6月、B组7.6月。 顺铂微球加碘化油栓塞的效果明显高于化疗药物碘化油栓塞的效果。
The mean survival time was 10.6 months and 7.6 months in group A and group B respectively.
应用推荐